GLP-1 receptor agonists available in the UK include: Semaglutide (Ozempic, Wegovy, Rybelsus) - Ozempic and Rybelsus for diabetes, Wegovy for weight management Dulaglutide (Trulicity) Liraglutide (Victoza, Saxenda) - Victoza for diabetes, Saxenda for weight management Lixisenatide (Lyxumia) Exenatide (Byetta, Bydureon) - though usage has declined in recent years These medications are administered either as once-daily, once-weekly, or twice-daily subcutaneous injections, with one oral formulation (semaglutide) also available
The result is reduced anxiety with improved cognitive function
Heres what well cover in this blog post: Why commitment matters for GLP-1 therapy The different stages of GLP-1 therapy What to expect after 18 months When considering getting started with GLP-1, its easy to wonder what the commitment will be: how long do you have to commit to get the results youre looking for, and when does the commitment end
The high incidence of obesity, its impact on life expectancy in adults and children, and the lack of safe therapeutic agents, have fuelled an increase in anti-obesity drug-related research
